Results 251 to 260 of about 399,723 (373)

Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer

, 2007
Birgitte Vrou Offersen, Rikke Riisbro, Ann Knoop, Nils Brünner, Jens Overgaard   +4 more
openalex   +1 more source

Cellular and molecular cross‐talk in atrial fibrillation: The role of non‐cardiomyocytes in creating an arrhythmogenic substrate

The Journal of Physiology, EarlyView.
Abstract figure legend Illustration of cellular and molecular cross‐talk in atrial fibrillation. Left: a schematic of cardiac tissue showing cardiomyocytes, fibroblasts, adipocytes, inflammatory cells and the coagulation system. Right: direct and indirect cross‐talk between different cell types, with the impact of direct cross‐talk on action potential (
Zhenyu Dong, Ruben Coronel, Joris R. de Groot   +2 more
wiley   +1 more source

Association Between Venous Mesenteric Thrombosis and Plasminogen Activator Inhibitor-1 Mutation. [PDF]

Cureus
Pereira V, Castanheira D, Sanches M, Castro Silva B, Almeida R.   +4 more
europepmc   +1 more source

Plasminogen Activator Inhibitor-1 Deficiency and Aging Contribute to Upregulation of Profibrotic Pathways, Cardiac Fibrosis, and Alterations of Myocardial Function in Mice [PDF]

, 2007
William Bradham, Linda A. Gleaves, Mousumi Medda, Douglas E. Vaughan   +3 more
openalex   +1 more source

Computational modelling of cardiac fibroblast signalling reveals a key role for Ca2+ in driving atrial fibrillation‐associated fibrosis

The Journal of Physiology, EarlyView.
Abstract figure legend A pre‐existing fibroblast signalling model was enhanced by integrating atrial‐specific components and reactions linked to atrial fibrosis and atrial fibrillation (AF). The analysis highlights the central role of Ca2⁺ signalling in driving profibrotic responses to AF‐relevant stimuli, angiotensin‐II and transforming growth factor ...
Najme Khorasani, Haibo Ni, Jeffrey J Saucerman, Dobromir Dobrev, Stefano Morotti, Eleonora Grandi   +5 more
wiley   +1 more source

Serum Levels of Plasminogen Activator Inhibitor-1 in Patients with Parkinson's Disease. [PDF]

Med Princ Pract
Tanrikulu AM, Ozdilek B, Agirbasli M.
europepmc   +1 more source

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

Diabetes, 2004
Li-jun Ma, Su-Li Mao, K. Taylor, T. Kanjanabuch, Y. Guan, Yahua Zhang, N. Brown, L. Swift, O. McGuinness, D. Wasserman, D. Vaughan, A. Fogo   +11 more
semanticscholar   +1 more source

Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.

, 2000
Janusz Błasiak, Beata Smolarz
openalex   +2 more sources

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, Volume 46, Issue 2, Page 475-512, March 2026.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

An updated systematic review and meta-analysis: correlation between circulating plasminogen activator inhibitor-1 levels and metabolic dysfunction-associated steatotic liver disease. [PDF]

BMC Gastroenterol
Li Q, Ruan Y, Zhu Y, Cai Y, Wu K, Shen C, Zhang Q, Chen S, Hu J, Liu S, Wang M.   +10 more
europepmc   +1 more source